Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 4, 2003, Pages 953-962

  Fiorino, Claudio ^a   Sanguineti, Giuseppe ^b   Cozzarini, Cesare ^a   Fellin, Gianni ^c   Foppiano, Franca ^b   Menegotti, Loris ^c   Piazzolla, Anna ^d   Vavassori, Vittorio ^d   Valdagni, Riccardo ^e  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c SANTA CHIARA HOSPITAL   (Italy)

^d OSPEDALE DI CIRCOLO   (Italy)

^e Casa di Cura PioX ^*  (Italy)

Author keywords

Conformal radiotherapy; Dose volume histograms; Prostate cancer; Rectal bleeding

Indexed keywords

CORRELATION METHODS; RADIOTHERAPY; TUMORS;

LOCALIZED PROSTATE CANCERS;

ONCOLOGY;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIATION DOSE DISTRIBUTION; RECTUM HEMORRHAGE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0142186671     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00665-5     Document Type: Article

References (49)

1. Storey M.R., Pollack A., Zagars G., et al. Complications from radiotherapy dose escalation in prostate cancer Preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys. 48:2000;635-642.
2. Michalski J.M., Winter K., Purdy J.A., et al. Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406. Semin Radiat Oncol. 12:(Suppl. 1):2002;75-80.
3. Zelefsky M.J., Cowen D., Fuks Z., et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer. 85:1999;2460-2468.
4. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500.
5. Pollack A., Zagars G., Starskschall G., et al. Prostate cancer radiation dose response Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 53:2002;1097-1105.
6. Perez C.A., Michalski J.M., Purdy J.A., et al. Three-dimensional conformal therapy or standard irradiation in localized carcinoma of prostate Preliminary results of a nonrandomized comparison. Int J Radiat Oncol Biol Phys. 47:2000;629-637.
7. Dearnaley D.P., Khoo V.S., Norman A.R., et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer A randomized trial. Lancet. 353:1999;267-272.
8. Hanks G.E., Hanlon A.L., Sculteiss T.E., et al. Dose escalation with 3D conformal treatment Five years outcomes, treatment optimization and future directions. Int J Radiat Oncol Biol Phys. 41:1998;501-510.
9. Hanks G.E., Hanlon A.L., Pinover W.H., et al. Survival advantage for prostate cancer treated with high-dose three-dimensional conformal radiotherapy. Cancer J Sci Am. 5:1999;152-158.
10. Lee R.W., Hanks G.E., Hanlon A.L., Schultheiss T.E., Hunt M.A. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer Further evidence for a significant dose effect. Int J Radiat Oncol Biol Phys. 35:1996;251-257.
11. Levitt S.H., Khan F.M. The rush to judgment Does the evidence support the enthusiasm over three-dimensional conformal radiation therapy and dose escalation in the treatment of prostate cancer? Int J Radiat Oncol Biol Phys. 51:2001;871-879.
12. Pollack A., Zagars G.K., Smith L.G., et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol. 18:2000;3904-3911.
13. Ling C.C., Burman C.M., Chui C.S., et al. Conformal radiation treatment of prostate cancer using inversely planned intensity-modulated photon beams produced with dynamic multileaf collimation. Int J Radiat Oncol Biol Phys. 35:1996;721-730.
14. Zelefsky M.J., Fuks Z., Hunt M., et al. High-dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol. 166:2001;876-881.
15. Zelefsky M.J., Fuks Z., Hunt M., et al. High-dose intensity modulated radiation therapy for prostate cancer Early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys. 53:2002;1111-1116.
16. Kupelian P.A., Reddy C.A., Carlson T.P., et al. Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer. Int J Radiat Oncol Biol Phys. 53:2002;904-912.
17. Lattanzi J., McNeeley S., Pinover W., et al. A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. Int J Radiat Oncol Biol Phys. 43:1999;719-725.
18. Morr J., DiPetrillo T., Tsai J.S., et al. Implementation and utility of a daily ultrasound-based localization system with intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 53:2002;1124-1129.
19. Vigneault E., Pouliot J., Laverdiere J., et al. Electronic portal imaging device detection of radio opaque markers for the evaluation of prostate position during megavoltage irradiation A clinical study. Int J Radiat Oncol Biol Phys. 37:1997;205-212.
20. Nederveen A.J., van der Heide U.A., Delmond H., et al. Measurements and clinical consequences of prostate motion during a radiotherapy fraction. Int J Radiat Oncol Biol Phys. 53:2002;206-214.
21. Kitamura K., Shirato H., Seppenwoolde Y., et al. Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions. Int J Radiat Oncol Biol Phys. 53:2002;1117-1123.
22. Van Herk M., Remeijer P., Rasch C., et al. The probability of correct target dosage Dose-population histogram for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys. 47:2000;1121-1135.
23. Jackson A. Partial irradiation of the rectum. Semin Radiat Oncol. 11:2001;215-223.
24. O'Brien P.C. Radiation injury of the rectum. Radiother Oncol. 60:2001;1-14.
25. Fiorino C., Cozzarini C., Vavassori V., et al. Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer Analysis of a large group of patients pooled from three institutions. Radiother Oncol. 64:2002;1-12.
26. Prescribing, recording and reporting photon beam therapy. 1993;ICRU, Bethesda, MD.
27. Fiorino C., Reni M., Bolognesi A., et al. Set-up error in supine-positioned patients immobilized with two different modalities during conformal radiotherapy of prostate cancer. Radiother Oncol. 49:1998;133-141.
28. Bedford J.L., Khoo V.S., Oldham M., Adams E.J., Dearneley D.P., Webb S. A comparison of coplanar 4-fields techniques for conformal radiotherapy of the prostate. Radiother Oncol. 52:1998;225-235.
29. Fiorino C., Reni M., Cattaneo G.M., Bolognesi A., Calandrino R. Comparing 3-, 4- and 6-fields techniques for conformal irradiation of prostate and seminal vesicles using dose-volume histograms. Radiother Oncol. 44:1997;251-257.
30. Fiorino C., Vavassori V., Sanguineti G., et al. Rectum contouring variability in patients treated for prostate cancer Impact on rectum DVHs and NTCP. Radiother Oncol. 63:2002;249-255.
31. Foppiano F., Fiorino C., Fellin G., et al. Retrospective multi-centric study (AIRO PROS01-01) on rectal toxicity in prostate cancer Evaluation of the uncertainty in rectum contouring. Radiother Oncol. 64:(Suppl. 1):2002;S280.
32. Declich F., Fiorino C., Masi L., et al. Comparing rectal DVH calculation with four commercial treatment planning systems by means of the AAPM TG23 18 MV unit. Radiother Oncol. 64:(Suppl. 1):2002;S318.
33. Boersma L.J., van den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys. 41:1998;83-92.
34. Fenwick J.D., Khoo V.S., Nahum A.E., Sanchez-Nieto B., Dearnaley D. Correlations between dose-surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 49:2001;473-480.
35. Fenwick J.D. Impact of dose-distribution uncertainties on rectal NTCP modelling II Uncertainty implications. Med Phys. 28:2001;570-581.
36. Hartford A.C., Niemierko A., Adams J.A., et al. Conformal irradiation of the prostate Estimating long-term rectal bleeding risk using dose-volume histograms. Int J Radiat Oncol Biol Phys. 36:1996;721-730.
37. Wachter S., Gerstner N., Goldner G., Potzi R., Wambersie A., Potter R. Endoscopic scoring of late rectal mucosa damage after conformal radiotherapy for prostatic carcinoma. Radiother Oncol. 54:2000;11-19.
38. Jackson A., Skwarchuk M.W., Zelefsky M.J., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer (II) Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys. 49:2001;685-698.
39. Cozzarini C., Fiorino C., Ceresoli G.L., et al. Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy). Int J Radiat Oncol Biol Phys. 55:2003;688-694.
40. Huang E.H., Pollack A., Levy L., Starkschall G.S., Dong L., Rosen I., Kuban D. Late rectal toxicity Dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 54:2002;1314-1321.
41. Lebesque J.V., Allison D., Bruce A.M., et al. Variation in volumes, dose-volume histograms and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int J Radiat Oncol Biol Phys. 33:1995;1109-1119.
42. Lu Y., Song P.Y., Li S.D., et al. A method of analyzing rectal surface area irradiated and rectal complications in prostate conformal radiotherapy. Int J Radiat Oncol Biol Phys. 33:1995;1121-1125.
43. MacKay R.I., Hendry J.H., Moore C.J., et al. Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose-surface histograms. Br J Radiol. 70:1997;517-526.
44. Mageras G.S., Kutcher G.J., Leibel S.A., et al. A method of incorporating organ motion uncertainties into three-dimensional conformal treatment plans. Int J Radiat Oncol Biol Phys. 35:1996;333-342.
45. Meijer G.J., van der Brink M., Hoogeman M.S., Meinders J., Lebesque J.V. Dose-wall histograms and normalized dose-surface histograms for the rectum A new method to analyze the dose distribution over the rectum in conformal radiotherapy. Int J Radiat Oncol Biol Phys. 45:1999;1073-1080.
46. Skwarchuk MW, Jackson A, Zelefsky M, Venkatram E, Cowen D, Burman C, Fuks Z, Leibel S, Ling C. Correlation of DVH and treatment planning variables with late rectal bleeding after 3D-CRT of prostate cancer: What is the best way to define the rectal length and volume? Int J Radiat Oncol Biol Phys 1999;(Suppl. 1) 261 (abstr.), 1999.
47. Gianolini S., Fiorino C., Calandrino R., Nahum A.E. On the relationship between dose-volume histogram (DVH/NDVH), dose-surface histogram (DSH/NDSH) and dose-wall histogram (DWH) of the rectum A cylindrical model and clinical examples. Radiother Oncol. 64:(Suppl. 1):2002;S280-S281.
48. Hoogeman M.S., de Bois J.A., Muller-Timmermans P., et al. The use of 2D-dose maps to determine the effect of organ motion on the use to the rectal wall. [Abstract] Radiother Oncol. 61:(Suppl. 1):2001;S37.
49. Seddon B., Bidmead M., Wilsn J., Khoo V., Dearnaley D. Target volume definition in conformal radiotherapy for prostate cancer Quality assurance in the MRC RT-01 trial. Radiother Oncol. 56:2000;73-83.